N‐terminal pro brain natriuretic peptide eliminates the prognostic effect of atrial fibrillation in patients with chronic heart failure

N‐terminal pro brain natriuretic peptide eliminates the prognostic effect of atrial fibrillation in patients with chronic heart failure

Abstract Aims Co‐morbid atrial fibrillation (AF) increases both mortality and N‐terminal pro brain natriuretic peptide (NT‐proBNP) concentrations in patients with chronic heart failure (CHF). It is unclear whether AF worsens prognosis independently from NT‐proBNP concentrations. If AF was an indepen...

Full description

Bibliographic Details
Main Authors:	Johannes Schnorbach, Hanna Fröhlich, Tobias Täger, Anna Corletto, Hugo A. Katus, Lutz Frankenstein
Format:	Article
Language:	English
Published:	Wiley 2019-08-01
Series:	ESC Heart Failure
Subjects:	Chronic heart failure Atrial fibrillation NT‐proBNP Prognosis
Online Access:	https://doi.org/10.1002/ehf2.12464

Similar Items

N-terminal Pro-Brain Natriuretic Peptide And Atrial Fibrillation
by: Jayachandran Thejus, et al.
Published: (2009-01-01)

N-Terminal Pro B-Type Natriuretic Peptide's Usefulness for Paroxysmal Atrial Fibrillation Detection Among Populations Carrying Cardiovascular Risk Factors
by: Elena Palà, et al.
Published: (2019-11-01)

miR−21 and NT-proBNP Correlate with Echocardiographic Parameters of Atrial Dysfunction and Predict Atrial Fibrillation
by: Jan-Thorben Sieweke, et al.
Published: (2020-04-01)

Supraventricular arrhythmia, N-terminal pro-brain natriuretic peptide and troponin T concentration in relation to incidence of atrial fibrillation: a prospective cohort study
by: Jun Xiao, et al.
Published: (2021-03-01)

Incidence of Atrial Fibrillation in Persons with Very High Serum Levels of N-Terminal Pro-B-Type Natriuretic Peptide: The Multi-Ethnic Study of Atherosclerosis
by: Weiss NS, et al.
Published: (2021-04-01)

Clinical correlation between N-terminal pro-b-type natriuretic peptide and angiographic coronary atherosclerosis
by: Demóstenes G.L. Ribeiro, et al.
Published: (2014-06-01)

Using N-terminal pro-B-type natriuretic peptide to diagnose cardiac abnormalities in children with dyspneaen with dyspnea
by: Zakaria Mukalla, et al.
Published: (2017-06-01)

Relationship of plasma level of NT- ProBNP with development of AF in CABG patients
by: Tanaray B, et al.
Published: (2010-10-01)

N-terminal-pro-brain natriuretic peptide is decreased in insulin dependent gestational diabetes mellitus: a prospective cohort trial
by: Gottsauner-Wolf Michael, et al.
Published: (2011-04-01)

The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population
by: Zhu Q, et al.
Published: (2016-02-01)

N-TerminalPro-B-TypeNatriuretic Peptide For Detecting Early Cardiac Dysfunction in Patients with Thyroid Dysfunction
by: Makbule Ulusoy, et al.
Published: (2013-09-01)

Atrial Fibrillation after Lung Cancer Surgery: Prediction, Prevention and Anticoagulation Management
by: Gennaro Carmine Semeraro, et al.
Published: (2021-08-01)

The Changes of Amino Terminal Pro B-type Natriuretic Peptide (NT-proBNP) Concentration and Left Ventricular Ejection Fraction on Doxorubicin Chemotherapy Patients
by: Telly Kamelia, et al.
Published: (2017-06-01)

BNP und NT-proBNP als Biomarker zur Detektion von paroxysmalem Vorhofflimmern bei Patienten mit kardiovaskulären Risikofaktoren
by: Grüter, Timo
Published: (2014)

N-terminal-pro-brain natriuretic peptide, but not brain natriuretic peptide, is increased in patients with severe obesity
by: F. Fernandes, et al.
Published: (2007-02-01)

N-terminal proBrain Natriuretic Peptide as Indicator of Left Ventricle Hypertrophy In Hypertensive Patients Compared with Left Ventricle Mass Index in Echocardiography
by: Mohammad Ariful Munir, et al.
Published: (2013-06-01)

New Risk Markers in Atrial Fibrillation
by: Hijazi, Ziad
Published: (2013)

Correlation between Heart Failure with N-Terminal-Pro-B Type Natriuretic Peptide and Cardiothoracic Ratio from Chest Radiograph in Pediatric Heart Disease
by: Worawan Jittham
Published: (2019-09-01)

Effect of feline characteristics on plasma N‐terminal‐prohormone B‐type natriuretic peptide concentration and comparison of a point‐of‐care test and an ELISA test
by: Sofia Hanås, et al.
Published: (2020-05-01)

N-Terminal Prohormone of Brain Natriuretic Peptide but not C-Terminal Pre-Pro Vasopressin (Copeptin) Level is Associated with the Response to Antihypertensive Therapy in Haemodialysis Patients
by: Katarzyna Wyskida, et al.
Published: (2017-11-01)

Value of circulating N-terminal pro-brain natriuretic peptide for prognosis of cardiovascular events in patients with non-Hodgkin lymphoma in remission
by: B. B. Samura
Published: (2015-12-01)

Left ventricular diastolic dysfunction and N-terminal probrain sodium-uretic peptid level in patients with atrial fibrillation
by: Dzyak G.V., et al.
Published: (2013-06-01)

NT-proBNP in Isolated Diastolic Dysfunction
by: Kenan İltümür, et al.
Published: (2005-01-01)

The predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart failure
by: Fu S, et al.
Published: (2015-01-01)

Predictive value of circulating N-terminal pro-brain natriuretic peptide in patients after treatment of Hodgkin lymphoma (a 3-year prospective study)
by: B. B. Samura
Published: (2017-12-01)

Diagnostic value of NT–PRO BNP in cardiogenic and non cardiogenic pleural effusions
by: Mohamed E. Abdalla, et al.
Published: (2012-07-01)

N-terminal prohormone brain natriuretic peptide (NT-proBNP) as a noninvasive marker for restrictive syndromes
by: C. Mady, et al.
Published: (2008-08-01)

N‐Terminal pro‐B‐type natriuretic peptide and stroke risk across a spectrum of cerebrovascular disease: The REasons for Geographic and Racial Differences in Stroke cohort
by: Kara K. Landry, et al.
Published: (2020-07-01)

The effects of central arterial pressure and autonomic dysfunction on elevations in N-terminal pro-B-type natriuretic peptide (NT-proBNP) in men with diabetes
by: S. Bunce, et al.
Published: (2008-04-01)

Valor prognóstico dos peptídeos natriuréticos BNP e NT-proBNP na estratificação de risco dos pacientes com estenose aórtica grave
by: Marcelo Katz
Published: (2009)

Valor prognóstico dos peptídeos natriuréticos BNP e NT-proBNP na estratificação de risco dos pacientes com estenose aórtica grave
by: Katz, Marcelo
Published: (2009)

Evaluation of Serum Levels of N-terminal Pro Brain Natriuretic Peptide and Atrial Natriuretic Peptide in Neonates with Respiratory Distress
by: Noor Mohammad Noori, et al.
Published: (2016-06-01)

Point‐of‐care N‐terminal pro B‐type natriuretic peptide assay to screen apparently healthy cats for cardiac disease in general practice
by: Ta‐Li Lu, et al.
Published: (2021-07-01)

Diagnostic value of cardiac troponin I and N-terminal pro-B-Type Natriuretic Peptide in cardiac syncope
by: Yan Liang, et al.
Published: (2021-01-01)

Influence of preoperative serum N-terminal pro-brain type natriuretic peptide on the postoperative outcome and survival rates of coronary artery bypass patients
by: Thomas Schachner, et al.
Published: (2010-01-01)

Baseline NT-Pro-BNP Levels and Arrhythmia Recurrence in Outpatients Undergoing Elective Cardioversion of Persistent Atrial Fibrillation: A Survival Analysis
by: Tommaso Sanna, et al.
Published: (2009-01-01)

Age-adjusted plasma N-terminal pro-brain natriuretic peptide level in Kawasaki disease
by: Heul Jun, et al.
Published: (2016-07-01)

N-terminal natriuretic propeptide type-b (NT-proBNP) and left ventricular ejection fraction in acute phase of st-segment elevation myocardial infarction and 1-year later
by: Jernej Markež, et al.
Published: (2007-11-01)

Role of N-terminal pro-B-type natriuretic peptide in the prediction of outcomes in ST-elevation myocardial infarction complicated by cardiogenic shock
by: Yash Paul Sharma, et al.
Published: (2020-07-01)

Urinary N‐terminal pro‐brain natriuretic peptide: prognostic value in patients with acute chest pain
by: Stefanie Reynen, et al.
Published: (2021-06-01)